Include sunscreen on the essential medicine list: Doctors with disability write to WHO
NEW DELHI: Often mocked as "Suraj-mukhi" (sun-facing) or "Angrez" (British) due to their pale skin tone, as many as two lakh Indians, including health professionals, suffering from Albinism - a rare genetic condition - face daily exposure to harmful UV radiation and social discrimination.
Taking up their cause, Doctors with Disabilities: Agents of Change, a body of health professionals with disabilities for social justice, has written to the 25th World Health Organisation (WHO) Expert Committee on the Selection and Use of Essential Medicines, to include sunscreen on the Essential Medicines List.
In the letter to the members of the expert committee, Dr Satendra Singh, the group's founder and a noted disability rights champion, said, 'We write to express our strong and wholehearted support for the inclusion of sunscreen on the WHO Model List of Essential Medicines, a matter to be discussed at your forthcoming 25th meeting in Geneva, from May 5 to 9.'
'Adopting this critical decision is not only a matter of public health - it is a climate justice and human rights imperative. Sunscreen is far more than a cosmetic product. It is a vital, life-saving medical intervention, particularly for persons with albinism, who face unique biological vulnerabilities to ultraviolet (UV) radiation,' Dr Singh, who is also a Director Professor of the Department of Physiology, University College of Medical Sciences and G.T.B Hospital, Delhi, said.
'This is especially critical in regions with high UV exposure, where individuals with albinism often lack access to affordable, adequate sun protection. The consequences are dire: disproportionately high rates of skin damage, disfigurement, and preventable mortality due to skin cancer,' the letter, dated April 20, said.
In India alone, over 200,000 individuals, including health professionals, live with albinism, a rare genetic condition caused by mutations or changes in certain genes that affect the amount of melanin the body produces. Melanin controls the pigmentation (colour) of the skin, eyes, and hair.
Highlighting that people suffering from Albinism are often subjected to social discrimination and harmful stereotypes due to their pale skin tone, the letter further said, 'Ironically, in a society where light skin is often idealised and dark skin is stigmatised, individuals with albinism still face prejudice, exclusion, and mockery, compounding their already fragile health condition.'
'Their experience highlights how social and structural discrimination exacerbates health inequities, especially in low-resource settings,' the letter said.
Dr Singh quoted the United Nations Independent Expert on the Enjoyment of Human Rights by Persons with Albinism 2023 report, which reaffirmed that sunscreen must be recognised and treated as an essential health product, not a luxury or cosmetic item.
'We echo that view and emphasise that the failure to provide equitable access to sunscreen is a manifestation of systemic health inequity affecting marginalised populations,' Dr Singh, who is also co-chair of the International Council for Disability Inclusion in Medical Education, said.
'Including sunscreen in the WHO Essential Medicines List would mark a historic and science-based step forward, affirming the Committee's commitment to inclusive, equitable, and rights-based global health policy. It would also signal leadership in addressing the intersections of disability, climate vulnerability, and access to care,' the letter added.
'We respectfully urge the Committee to seize this opportunity to protect lives, advance health equity, and uphold the rights and dignity of people with albinism and other vulnerable groups worldwide,' it added.
Dr Singh further emphasised that sunscreen is the shield and not a luxury but a necessity for people suffering from Albinism.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
&w=3840&q=100)
First Post
2 hours ago
- First Post
Federal judge strikes down Trump's anti-diversity and anti-transgender grants
U.S. District Judge Jon Tigar said Monday that the federal government cannot force recipients to halt programs that promote diversity, equity and inclusion or acknowledge the existence of transgender people in order to receive grant funding read more A federal judge in California has blocked the Trump administration from enforcing anti-diversity and anti-transgender executive orders in grant funding requirements that LGBTQ+ organizations say are unconstitutional. U.S. District Judge Jon Tigar said Monday that the federal government cannot force recipients to halt programs that promote diversity, equity and inclusion or acknowledge the existence of transgender people in order to receive grant funding. The order will remain in effect while the legal case continues, although government lawyers will likely appeal. STORY CONTINUES BELOW THIS AD The funding provisions 'reflect an effort to censor constitutionally protected speech and services promoting DEI and recognizing the existence of transgender individuals,' Tigar wrote. He went on to say that the executive branch must still be bound by the Constitution in shaping its agenda and that even in the context of federal subsidies, 'it cannot weaponize Congressionally appropriated funds to single out protected communities for disfavored treatment or suppress ideas that it does not like or has deemed dangerous.' More from World Mpox epidemic remains international health emergency warns WHO The plaintiffs include health centers, LGBTQ+ services groups and the Gay Lesbian Bisexual Transgender Historical Society. All receive federal funding and say they cannot complete their missions by following the president's executive orders. The San Francisco AIDS Foundation, one of the plaintiffs, said in 2023 it received a five-year grant from the Centers for Disease Control and Prevention to expand and enhance sexual health services, including the prevention of sexually transmitted infections. The $1.3 million project specifically targets communities disproportionately affected by sexual health disparities. But in April, the CDC informed the nonprofit that it must 'immediately terminate all programs, personnel, activities, or contracts' that promote DEI or gender ideology. President Donald Trump has signed a flurry of executive orders since taking office in January, including ones to roll back transgender protections and stop DEI programs. Lawyers for the government say that the president is permitted to 'align government funding and enforcement strategies' with his policies. Plaintiffs say that Congress — and not the president — has the power to condition how federal funds are used, and that the executive orders restrict free speech rights.
&w=3840&q=100)
First Post
2 hours ago
- First Post
Mpox epidemic remains international health emergency warns WHO
The WHO said that since the outbreak began in early 2024 in the Democratic Republic of the Congo, there have been over 37,000 cases in 25 nations, with 125 deaths read more The World Health Organisation stated Monday that the mpox virus epidemic is still an international health emergency, with almost 37,000 confirmed cases documented since it began. WHO Director General Tedros Adhanom Ghebreyesus declared the continuation of the emergency following a conference of international specialists, who acknowledged improvement in certain countries but also highlighted a rise in West Africa and the virus's spread beyond Africa. The WHO said that since the outbreak began in early 2024 in the Democratic Republic of the Congo, there have been over 37,000 cases in 25 nations, with 125 deaths. STORY CONTINUES BELOW THIS AD DR Congo is responsible for 60% of verified cases and 40% of deaths from the virus, which causes a rash and severe flu-like symptoms. Uganda and Burundi have been the next worst hit, followed by Sierra Leone, which the WHO said has seen a surge in cases this year. WHO first declared mpox an international emergency in August last year. The International Health Regulations emergency committee met last Thursday to discuss the epidemic. It decided that the epidemic remains an international emergency 'based on the continuing rise in the number of cases, including a recent increase in West Africa, and likely ongoing undetected transmission in some countries beyond the African continent.' It said some countries were still struggling to monitor the epidemic and with a lack of funding for treatment there was a need for 'continued international support'.
Time of India
4 hours ago
- Time of India
Measles cases surging globally. Should children be vaccinated earlier?
Sydney: Measles has been rising globally in recent years. There were an estimated 10.3 million cases worldwide in 2023, a 20 per cent increase from 2022. Outbreaks are being reported all over the world including in the United States, Europe and the Western Pacific region (which includes Australia ). For example, Vietnam has reportedly seen thousands of cases in 2024 and 2025. In Australia, 77 cases of measles have been recorded in the first five months of 2025, compared with 57 cases in all of 2024. Measles cases in Australia are almost all related to international travel. They occur in travellers returning from overseas, or are contracted locally after mixing with an infected traveller or their contacts. Measles most commonly affects children and is preventable with vaccination, given in Australia in two doses at 12 and 18 months old. But in light of current outbreaks globally, is there a case for reviewing the timing of measles vaccinations? Some measles basics Measles is caused by a virus belonging to the genus Morbillivirus. Symptoms include a fever, cough, runny nose and a rash. While it presents as a mild illness in most cases, measles can lead to severe disease requiring hospitalisation, and even death. Large outbreaks can overwhelm health systems. Measles can have serious health consequences, such as in the brain and the immune system, years after the infection. Measles spreads from person to person via small respiratory droplets that can remain suspended in the air for two hours. It's highly contagious - one person with measles can spread the infection to 12-18 people who aren't immune. Because measles is so infectious, the World Health Organization (WHO) recommends two-dose vaccination coverage above 95 per cent to stop the spread and achieve "herd immunity". Low and declining vaccine coverage, especially since the COVID pandemic, is driving global outbreaks. When are children vaccinated against measles? Newborn babies are generally protected against measles thanks to maternal antibodies. Maternal antibodies get passed from the mother to the baby via the placenta and in breast milk, and provide protection against infections including measles. The WHO advises everyone should receive two doses of measles vaccination. In places where there's a lot of measles circulating, children are generally recommended to have the first dose at around nine months old. This is because it's expected maternal antibodies would have declined significantly in most infants by that age, leaving them vulnerable to infection. If maternal measles antibodies are still present, the vaccine is less likely to produce an immune response. Research has also shown a measles vaccine given at less than 8.5 months of age can result in an antibody response which declines more quickly. This might be due to interference with maternal antibodies, but researchers are still trying to understand the reasons for this. A second dose of the vaccine is usually given 6-9 months later. A second dose is important because about 10-15 per cent of children don't develop antibodies after the first vaccine. In settings where measles transmission is under better control, a first dose is recommended at 12 months of age. Vaccination at 12 months compared with nine months is considered to generate a stronger, longer-lasting immune response. In Australia, children are routinely given the measles-mumps- rubella ( MMR ) vaccine at 12 months and the measles-mumps-rubella-varicella (MMRV, with "varicella" being chickenpox) vaccine at 18 months. Babies at higher risk of catching the disease can also be given an additional early dose. In Australia, this is recommended for infants as young as six months when there's an outbreak or if they're travelling overseas to a high-risk setting. A new study looking at measles antibodies in babies A recent review looked at measles antibody data from babies under nine months old living in low- and middle-income countries. The review combined the results from 20 studies, including more than 8,000 babies. The researchers found that while 81 per cent of newborns had maternal antibodies to measles, only 30 per cent of babies aged four months had maternal antibodies. This study suggests maternal antibodies to measles decline much earlier than previously thought. It raises the question of whether the first dose of measles vaccine is given too late to maximise infants' protection, especially when there's a lot of measles around. Should we bring the measles vaccine forward in Australia? All of the data in this study comes from low- and middle-income countries, and might not reflect the situation in Australia where we have much higher vaccine coverage for measles, and very few cases. Australia's coverage for two doses of the MMR vaccine at age two is above 92 per cent. Although this is lower than the optimal 95 per cent, the overall risk of measles surging in Australia is relatively low. Nonetheless, there may be a case for broadening the age at which an early extra dose of the measles vaccine can be given to children at higher risk. In New Zealand, infants as young as four months can receive a measles vaccine before travelling to an endemic country. But the current routine immunisation schedule in Australia is unlikely to change. Adding an extra dose to the schedule would be costly and logistically difficult. Lowering the age for the first dose may have some advantages in certain settings, and doesn't pose any safety concerns, but further evidence would be required to support this change. In particular, research is needed to ensure it wouldn't negatively affect the longer-term protection that vaccination offers from measles. Making sure you're protected In the meantime, ensuring high levels of measles vaccine coverage with two doses is a global priority. People born after 1966 are recommended to have two doses of measles vaccine. This is because those born before the mid-1960s likely caught measles as children (when the vaccine was not yet available) and would therefore have natural immunity. If you're unsure about your vaccination status, you can check this through the Australian Immunisation Register . If you don't have a documented record, ask your doctor for advice. Catch-up vaccination is available under the National Immunisation Programme . (The Conversation) PY PY
